Results 131 to 140 of about 134,591 (304)

Diuretics: A Clinical and Pharmacological Review

open access: yes
This thesis provides a comprehensive review from clinical and pharmacological perspectives on diuretics, with a primary focus on their role in managing cardiovascular diseases.
Chu, Ying Ju
core  

Randomized trial to assess worsening renal function by adding dapagliflozin for acute decompensated heart failure

open access: yesESC Heart Failure
Aims Dapagliflozin (DAPA), a sodium‐glucose co‐transporter 2 inhibitor, has been shown to reduce cardiovascular mortality among patients with chronic heart failure.
Shodai Kawanami   +11 more
doaj   +1 more source

Cardiac remodelling in the era of the recommended four pillars heart failure medical therapy

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1029-1044, April 2025.
Abstract Cardiac remodelling is a key determinant of worse cardiovascular outcome in patients with heart failure (HF) and reduced ejection fraction (HFrEF). It affects both the left ventricle (LV) structure and function as well as the left atrium (LA) and the right ventricle (RV).
Giada Colombo   +7 more
wiley   +1 more source

Diuretics and Their Application

open access: yes, 2022
Reviewed in the literature of this thesis are the classes of diuretic drugs and their mechanism of action, the form of diuretic therapy taken depending on the kind of illness, the different drug interactions, and adverse effects different classes of ...
Akinmosin, Oladipo Samson
core  

Efficacy of ambulatory intravenous diuresis for chronic heart failure patients: Insights from the DEA‐HF trial

open access: yesESC Heart Failure
Aims Oral diuretic treatment has limited efficacy in managing chronic heart failure (HF) patients. Novel strategies are needed to manage patients with refractory congestion despite optimal HF therapy and high‐dose oral diuretic treatment.
Amit Gruber   +14 more
doaj   +1 more source

Diuretics [PDF]

open access: yesPostgraduate Medical Journal, 1933
openaire   +2 more sources

Left ventricular function improvement during angiotensin receptor–neprilysin inhibitor treatment in a cohort of HFrEF/HFmrEF patients

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1151-1165, April 2025.
Prediction of LVEF improvement in patients with HFrEF and HFmrEF following treatment with Sacubitril/Valsartan. Workflow of this study investigating the functional capacity improvement in response to Sacubitrail/Valsartsan in a real‐world scenario of heart failure treatment.
Florian Appenzeller   +8 more
wiley   +1 more source

Improving arterial hypertension control in patients with high cardiovascular event risk: main stages of Russian Research and Clinical Program ARGUS-2

open access: yesКардиоваскулярная терапия и профилактика, 2006
Principal results of the Russian Research and Clinical Program ARGUS. In this patient group, arterial hypertension (AH) control is very low, as well as diuretic prescription rate. High AH-related hospitalization rate is an evidence of a need for studying
A. I. Martynov   +5 more
doaj  

The effects of sodium–glucose cotransporter 2 inhibitors on the ‘forgotten’ right ventricle

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1045-1058, April 2025.
Abstract With the progress in diagnosis, treatment and imaging techniques, there is a growing recognition that impaired right ventricular (RV) function profoundly affects the prognosis of patients with heart failure (HF), irrespective of their left ventricular ejection fraction (LVEF).
Liangzhen Qu, Xueting Duan, Han Chen
wiley   +1 more source

Management of acute heart failure in the intensive care unit

open access: yesJournal of Pediatric Critical Care
Pediatric heart failure (PHF) is a heterogeneous syndrome arising from varied etiologies including congenital heart disease, genetic, infective, inflammatory, and metabolic disorders. The aim of acute heart failure (HF) management is to achieve euvolemic
Chidhambharam Lakshmanan   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy